Antiobesity drug rimonabant linked to anxiety and depressionBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39402.625544.BE (Published 22 November 2007) Cite this as: BMJ 2007;335:1070
Two recent reports have uncovered a worrying link between the antiobesity drug rimonabant and mental health problems, including suicide, says an editorial (p 1671)⇑. The first, a meta-analysis of four key trials, found that obese people who took the drug were two and half …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial